Alcon Inc
ALC: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| DVm | LOCK|dF?@ | LOCK|cV#P@! |
Alcon's Solid Execution and New Innovation Spark Market Penetration and Long-Term Growth
Business Strategy and Outlook
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: vision care and surgical.
